{"id":998432,"date":"2026-08-27T07:05:25","date_gmt":"2026-08-27T11:05:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/"},"modified":"2026-08-27T07:05:25","modified_gmt":"2026-08-27T11:05:25","slug":"novabridge-biosciences-to-participate-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/","title":{"rendered":"NovaBridge Biosciences to Participate in September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ROCKVILLE, Md., Aug.  27, 2026  (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (Nasdaq: NBP) (\u201cNovaBridge\u201d or the \u201cCompany\u201d), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company\u2019s leadership will participate in the following investor conferences in September 2026:<\/p>\n<p align=\"justify\">Conference details:<\/p>\n<p align=\"justify\">\n        <strong>Cantor 2026 Global Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and one-on-one meetings<br \/>Presenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge Biosciences<br \/>Date: Thursday, September 10, 2026<br \/>Time: 1:00 PM ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yx2Qe9BATolFjURxUbZOAojdY0NagVsCyJtSq2s-RugpBrxgi8BNy7XlxjlV4TQKTYG7rf9d5duT8niGreecVLXqufFjNHcCc0LUTBx5QzVTw1tlYSnd0M_q_n3gKceh57T7YDcREltTOwaElTW-CF0axUtLmvqiXUNAB7SNJf-9GR3U6sa2jdmw3K1hiQ2gmYdfHzdIJjZK9Pv1P-5huYDn2qhE5z159eNYp887d1s=\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p align=\"justify\">\n        <strong>H.C. Wainwright 28<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and one-on-one meetings<br \/>Presenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge Biosciences<br \/>Date: Monday, September 14, 2026<br \/>Time: 9:30 AM ET<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yx2Qe9BATolFjURxUbZOAnQeV6n2ZzwIbD9G8KJB1n0gbh4eEQPCWVzFkBfMXWiJy62FC7bJzgyHi8DdcR1XzjmdhxtnHR-S7fc9GRWf3eEreStSYeJeEztsnRcbjQZv5pJdALhC038S8u_iyhPHvQ==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p align=\"justify\">Webcasts of the Fireside chats will be accessible in the News &amp; Events page of the\u00a0NovaBridge\u00a0website for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About NovaBridge<\/strong>\n      <\/p>\n<p align=\"justify\">NovaBridge Biosciences (Nasdaq: NBP) is a global biotechnology company advancing a portfolio of therapeutic programs in oncology and ophthalmology. The Company identifies differentiated therapeutic opportunities, generates value-defining clinical evidence, and applies the development, financing, and partnering strategy best suited to each program.<\/p>\n<p align=\"justify\">NovaBridge\u2019s portfolio is led by givastomig and VIS-101. The Company&#8217;s objective is to build a sustainable biotechnology company by repeatedly identifying differentiated innovation, advancing it efficiently, and bringing novel therapies to patients through the path best suited to each opportunity.<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eogmn-kZMZiXWchoQPCsMvVXu1yfb6AlshOeHYyfgvNdsJ1QpB5Vn0i_0awsGDYQsAzf-3VG7Y6XiEOfAcLlBdIHxZtvDde9ZPjYcd-pCnQ=\" rel=\"nofollow\" target=\"_blank\"><u>www.novabridge.com<\/u><\/a> and follow us on LinkedIn.<\/p>\n<p align=\"justify\">\n        <strong>NovaBridge Investor &amp; Media Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">NovaBridge Biosciences<br \/>+1-240-745-6330<br \/>IR@novabridge.com<\/p>\n<p align=\"justify\">Bill Begien, VP, Investor Relations<br \/>bill.begien@novabridge.com<\/p>\n<p align=\"justify\">Jessica Zhang, Director, Public Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ssKOBJ-OzoNcITczA6bjRf3d6HASi7lRC-nk4IlgSE_Dyt4S3A1CufZXOIN9x3r3RcbtIkYY23cn7HbnIdMYccAeiATPWGksouU3_XPjVEf6KY8vL-TTRSN_t8j9bPve\" rel=\"nofollow\" target=\"_blank\">jessica.zhang@novabridge.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjUzMzcwZDctODE0ZC00M2FhLTg4ZDctOTBkMWMxZThhOWQ2LTUwMDEyNTAyOS0yMDI2LTA4LTI3LWVu\/tiny\/NovaBridge-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (Nasdaq: NBP) (\u201cNovaBridge\u201d or the \u201cCompany\u201d), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company\u2019s leadership will participate in the following investor conferences in September 2026: Conference details: Cantor 2026 Global Healthcare Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Thursday, September 10, 2026Time: 1:00 PM ETWebcast Link: Here H.C. Wainwright 28 th Annual Global Investment Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Monday, September 14, 2026Time: 9:30 AM ETWebcast Link: Here Webcasts of the Fireside chats will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NovaBridge Biosciences to Participate in September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998432","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (Nasdaq: NBP) (\u201cNovaBridge\u201d or the \u201cCompany\u201d), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company\u2019s leadership will participate in the following investor conferences in September 2026: Conference details: Cantor 2026 Global Healthcare Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Thursday, September 10, 2026Time: 1:00 PM ETWebcast Link: Here H.C. Wainwright 28 th Annual Global Investment Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Monday, September 14, 2026Time: 9:30 AM ETWebcast Link: Here Webcasts of the Fireside chats will &hellip; Continue reading &quot;NovaBridge Biosciences to Participate in September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T11:05:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NovaBridge Biosciences to Participate in September Investor Conferences\",\"datePublished\":\"2026-08-27T11:05:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/\",\"name\":\"NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\",\"datePublished\":\"2026-08-27T11:05:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novabridge-biosciences-to-participate-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NovaBridge Biosciences to Participate in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk","og_description":"ROCKVILLE, Md., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; NovaBridge Biosciences (Nasdaq: NBP) (\u201cNovaBridge\u201d or the \u201cCompany\u201d), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that the Company\u2019s leadership will participate in the following investor conferences in September 2026: Conference details: Cantor 2026 Global Healthcare Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Thursday, September 10, 2026Time: 1:00 PM ETWebcast Link: Here H.C. Wainwright 28 th Annual Global Investment Conference Format: Fireside Chat and one-on-one meetingsPresenter: Srishti Gupta, MD, MPP, Chief Executive Officer, NovaBridge BiosciencesDate: Monday, September 14, 2026Time: 9:30 AM ETWebcast Link: Here Webcasts of the Fireside chats will &hellip; Continue reading \"NovaBridge Biosciences to Participate in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-27T11:05:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NovaBridge Biosciences to Participate in September Investor Conferences","datePublished":"2026-08-27T11:05:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/","name":"NovaBridge Biosciences to Participate in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==","datePublished":"2026-08-27T11:05:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjcxNiM3ODA0OTgxIzUwMDEyNTAyOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novabridge-biosciences-to-participate-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NovaBridge Biosciences to Participate in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998432"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998432\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}